SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-24-035049
Filing Date
2024-02-14
Accepted
2024-02-14 07:22:25
Documents
2
Group Members
BALYASNY ASSET MANAGEMENT HOLDINGS LPBAM GP LLCDAMES GP LLCDMITRY BALYASNY

Document Format Files

Seq Description Document Type Size
1 SC 13G d753345dsc13g.htm SC 13G 118760
2 EX-99.1 d753345dex991.htm EX-99.1 6348
  Complete submission text file 0001193125-24-035049.txt   126991
Mailing Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606
Business Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606 312.499.2999
BALYASNY ASSET MANAGEMENT L.P. (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 840 MEMORIAL DRIVE CAMBRIDGE MA 02139 617-498-0020
Mersana Therapeutics, Inc. (Subject) CIK: 0001442836 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-90033 | Film No.: 24632271
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)